We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.6%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$323M
AUM Growth
-$70.1M
(-18%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-3.77%
Top 10 Holdings %
Top 10 Hldgs %
57.75%
Holding
64
New
17
Increased
10
Reduced
12
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$17M |
| 2 |
Pfizer
PFE
|
+$15.9M |
| 3 |
Teleflex
TFX
|
+$14.6M |
| 4 |
Travere Therapeutics
TVTX
|
+$12.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$26M |
| 2 |
Cigna
CI
|
+$15.5M |
| 3 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$8.28M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$8.15M |
| 5 |
Humana
HUM
|
+$5.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Humacyte Inc Warrant
HUMAW
$1.1M
| $33.4K | 0.01% |
49,998
| – | – |
|
|
CMAXW
52
DELISTED
CareMax, Inc. Warrant
CMAXW
| $2.37K | ﹤0.01% |
12,808
| – | – |
|
53
PUT
Align Technology
ALGN
$12.3B
| – | – |
-34,500
| Closed | -$12.2M |
|
|
KYNB
54
Kyntra Bio
KYNB
$28.3M
| – | – |
-464
| Closed | -$31.3K |
|
|
KYNB
55
PUT
Kyntra Bio
KYNB
$28.3M
| – | – |
-464
| Closed | -$31.3K |
|
|
56
Humana
HUM
$43B
| – | – |
-13,000
| Closed | -$5.81M |
|
57
PUT
Intuitive Surgical
ISRG
$132B
| – | – |
-35,500
| Closed | -$12.1M |
|
58
PUT
Medifast
MED
$137M
| – | – |
-190,000
| Closed | -$17.5M |
|
59
Nektar Therapeutics
NKTR
$2.48B
| – | – |
-466,359
| Closed | -$4.02M |
|
60
PUT
Stryker
SYK
$129B
| – | – |
-80,000
| Closed | -$24.4M |
|
|
PDCO
61
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-245,000
| Closed | -$8.15M |
|
|
AXNX
62
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – |
-164,017
| Closed | -$8.28M |
|
|
SWAV
63
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-154,400
| Closed | -$44.1M |
|
|
VRAY
64
DELISTED
ViewRay, Inc.
VRAY
| – | – |
-6,431,349
| Closed | -$2.27M |
|
Similar funds
GUB
KLI
JA
AAM
TCM
CA
SAM
ACM
Sio Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Sio Capital Management held 64 positions worth $323M, down 18% from $393M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Sio Capital Management withdrew a net $12.2M in Q3 2023, closing 12 positions and reducing 12 holdings. Its most notable exit was Axonics, Inc. Common Stock, an estimated $8.28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 71% a quarter earlier.
Against the trend, Sio Capital Management opened a new position in Pfizer worth $14.9M.
- Sio Capital Management's largest Q3 2023 buy was Pfizer: 450,700 shares worth $14.9M.
- Sio Capital Management added most to Globus Medical in Q3 2023, an estimated $17M increase.
- Sio Capital Management's biggest Q3 2023 reduction was GE HealthCare, cutting an estimated $26M.
- Sio Capital Management fully exited Axonics, Inc. Common Stock in Q3 2023, selling an estimated $8.28M.
- Sio Capital Management's ten largest holdings make up 58% of its $323M portfolio in Q3 2023.
- Sio Capital Management opened 17 new positions and closed 12 in Q3 2023.
- Sio Capital Management's portfolio value fell 18% quarter-over-quarter to $323M.
Based on Sio Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.